| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.95▼ | 9.95▼ | 9.95▼ | 9.96▼ | 9.94▼ |
| MA10 | 9.95▲ | 9.95▲ | 9.95▲ | 9.95▼ | 9.94▲ |
| MA20 | 9.94▲ | 9.95▲ | 9.95▲ | 9.95▼ | 9.91▲ |
| MA50 | 9.95▲ | 9.94▲ | 9.94▲ | 9.94▲ | N/A |
| MA100 | 9.93▲ | N/A | N/A | 9.91▲ | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.001▲ | 0.001▲ | -0.001▼ | 0.000▲ |
| RSI | 51.277▲ | 51.634▲ | 51.762▲ | 46.791▼ | 59.441▲ |
| STOCH | 45.834 | 45.834 | 43.056 | 4.731▼ | 10.229▼ |
| WILL %R | -74.998 | -74.998 | -74.998 | -100.000▼ | -89.474▼ |
| CCI | 30.804 | 32.423 | 20.749 | -59.055 | 154.828▲ |
|
Wednesday, June 22, 2022 05:06 PM
The shares of BridgeBio Pharma (NASDAQ:BBIO) traded higher in the morning ... Canavan disease is caused by a mutation of the ASPA gene that codes for aspartoacylase (ASPA), a protein that breaks ...
|
|
Wednesday, June 22, 2022 10:57 AM
BridgeBio Pharma (NASDAQ:BBIO) announced early positive data ... brain-barrier and is expressing functional aspartoacylase (ASPA) enzyme. As the data reported are still early and the final ...
|
|
Wednesday, June 22, 2022 10:47 AM
The MarketWatch News Department was not involved in the creation of this content. PALO ALTO, Jun 22, 2022 (GLOBE NEWSWIRE via COMTEX) -- - These results are the first reported demonstration of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/06/22 | 9.94 | 9.94 | 9.94 | 9.94 | 30,054 |
| 29/06/22 | 9.95 | 9.9503 | 9.94 | 9.95 | 234,114 |
| 28/06/22 | 9.97 | 9.97 | 9.97 | 9.97 | 182 |
| 27/06/22 | 10.39 | 10.45 | 9.95 | 9.98 | 14,630 |
| 24/06/22 | 9.96 | 9.96 | 9.95 | 9.96 | 10,113 |
| 23/06/22 | 9.96 | 9.96 | 9.96 | 9.96 | 24 |
| 22/06/22 | 9.9493 | 9.96 | 9.9493 | 9.95 | 14,624 |
| 21/06/22 | 9.94 | 9.95 | 9.94 | 9.94 | 124 |
| 17/06/22 | 9.94 | 9.94 | 9.94 | 9.94 | 6 |
| 16/06/22 | 9.94 | 9.95 | 9.94 | 9.94 | 110,415 |
|
|
||||
|
|
||||
|
|